Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation

Emmanuel Messas1, Bruno Pouzet, Bernard Touchot

  • 1Faculté de Médecine Necker-Enfants Malades, INSERM EMI-0016, Ecole de Chirurgie, Assistance Publique - Hôpitaux de Paris, Service de Cardiologie 1 et de Chirurgie Cardio -Vasculaire, Hôpital Européen Georges Pompidou, Paris, France.

Circulation
|September 13, 2003
PubMed
Abstract

Insights

Cutting specific heart valve cords effectively treats chronic ischemic mitral regurgitation without negative effects. This minimally invasive procedure improves heart function and reduces mitral regurgitation in patients with ischemic heart disease.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Mechanics
  • Heart Valve Disease

Background:

  • Mitral regurgitation (MR) is a common complication of ischemic heart disease, often inadequately treated by standard methods due to leaflet tethering.
  • Chordal tethering to displaced papillary muscles restricts leaflet closure, leading to persistent MR despite left ventricular (LV) remodeling.
  • Previous acute models showed promise for chordal cutting to reduce MR, but efficacy in chronic conditions with advanced remodeling was unknown.

Purpose of the Study:

  • To evaluate the effectiveness of cutting specific basal chordae in reducing chronic persistent ischemic mitral regurgitation (MR) in a sheep model.
  • To assess the impact of this intervention on left ventricular (LV) function, valve geometry, and the incidence of prolapse or recurrent MR.
  • To determine the long-term safety and efficacy of chordal cutting in chronic ischemic MR.

Main Methods:

  • Seven sheep with chronic inferobasal infarcts and progressive MR underwent cutting of the two central basal chordae at the leaflet base.
  • 3-Dimensional echocardiography was used to quantify MR severity, LV function (ejection fraction), and valve geometry before and after the procedure.
  • Five additional sheep were followed long-term after inferobasal infarction and chordal cutting to assess sustained effects.

Main Results:

  • Cutting the central basal chordae significantly reduced MR in all 7 sheep, restoring it to baseline levels (regurgitant fraction decreased significantly, P<0.0001).
  • The procedure effectively improved leaflet coaptation without causing valve prolapse or a decline in LV ejection fraction (EF) (41.1% to 42.6%, P=NS).
  • Long-term follow-up in 5 sheep showed no evidence of prolapse or recurrent MR, and no significant decrease in post-infarct LVEF.

Conclusions:

  • A minimally invasive approach of cutting a few basal chordae effectively reduces chronic persistent ischemic MR by improving leaflet coaptation.
  • This technique offers a promising therapeutic option for ischemic MR without compromising LV ejection fraction or causing adverse valve events.
  • Chordal cutting is safe and effective long-term, even when performed after significant LV remodeling due to infarction.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...